CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
Daniele Biasci(University of Cambridge), Duncan I. Jodrell(University of Cambridge)
Cited by 21
Related Papers
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
|Nature Genetics|2017|311
Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells
|British Journal of Cancer|2012|38